https://gaisce.bio/ 2026-06-06 monthly 1.0 https://gaisce.bio/assets/og-image.png Gaisce Biosciences — effective outpatient CAR-T for solid tumours Pre-clinical CAR-T cell therapy for solid tumours. https://gaisce.bio/assets/brand-mark.png Gaisce Biosciences g·b lettermark https://gaisce.bio/platform.html 2026-06-06 monthly 0.9 https://gaisce.bio/assets/og-image.png The Gaisce platform — one engineered cell, three systems https://gaisce.bio/pipeline.html 2026-06-06 monthly 0.9 https://gaisce.bio/assets/og-image.png Gaisce pipeline — lead programme and tumour-agnostic expansion https://gaisce.bio/approach.html 2026-06-06 monthly 0.8 https://gaisce.bio/assets/og-image.png How Gaisce de-risks — an engineered answer to every failure mode https://gaisce.bio/about.html 2026-06-06 monthly 0.8 https://gaisce.bio/assets/og-image.png About Gaisce Biosciences — investors and contact